Kardigan

About Kardigan

Kardigan is a heart health company dedicated to making cardiovascular disease preventable, curable, and no longer the leading cause of death worldwide. Their mission is to develop multiple targeted treatments in parallel, leveraging a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and a passionate team to improve patient outcomes and move beyond symptom management toward functional cures.

Products & Services

Personalized Cardiovascular Medicines:A portfolio of late-stage clinical candidates designed to target critical disease drivers, matching treatments with responders for effective patient segmentation and streamlined clinical trials.

Danicamtiv:A treatment for patients with Dilated Cardiomyopathy, with positive Phase 2a data presented at the HFSA Annual Scientific Meeting 2025.

Treatments for Acute Severe Hypertension:Part of Kardigan's late-stage portfolio targeting specific cardiovascular conditions.

Genetic Dilated Cardiomyopathy

Calcific Aortic Valve Stenosis

Acute Severe Hypertension

Specialties

Cardiovascular Drug Development Personalized Medicine AI-Enhanced Clinical Trials Cardiac Intelligence Translational Research Cardiovascular medicine Genetic heart diseases Cardiac intelligence

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: IPO T: - FT: IPO	A: 460000000 MR: - FA: $460M FAN: 460000000	D: 2026-06-30 FD: 2026-06-30	-
2	RT: IPO T: - FT: IPO	A: 460000000 MR: - FA: $460 million FAN: 460000000	D: 2026-06-22 FD: 2026-06-22	4 investors
3	RT: IPO T: - FT: IPO	A: 400000000 MR: - FA: $400 million FAN: 400000000	D: 2026-06-17 FD: 2026-06-17	4 investors
4	RT: Series B T: - FT: Series B	A: 254000000 MR: - FA: 254 million FAN: 254000000	D: 2025-10-14 FD: 2025-10-14	4 investors

IPO Latest

2026-06-30

$460.0M

IPO 2026-06-22

$460.0M

IPO 2026-06-17

$400.0M

View 3 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

T

Tassos Gianakakos

CO-FOUNDER & CEO

T

Tassos Gianakakos

CO-FOUNDER, CHIEF EXECUTIVE OFFICER AND CHAIR

J

Jay Edelberg

CO-FOUNDER AND CHIEF MEDICAL OFFICER

B

Bob McDowell

CO-FOUNDER AND SCIENTIFIC ADVISER

B

Brianne Puglisi

CHIEF FINANCIAL OFFICER

J

John Moriarty

CHIEF LEGAL OFFICER AND CORPORATE SECRETARY

View 8 more team members with Pro

Unlock Full Team Directory

Recent News

Kardigan Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised